In the early stages of ALI, damage to the endothelium and subsequent increase of vasoactive mediators such as ET-1, IL-6, and TNF-A can promote pulmonary vasoconstriction leading to increased PVR. This evidence concerns the gene IL6 and acute respiratory distress syndrome.